基于常规血液的炎症标志物与皮肤冠状动脉干预的患者的预后的关联

Li Kun Huo1,2, Kang Yin Chen1, Gary Tse1,3,4

  • 1Department of Cardiology, Tianjin Key Laboratory of Ions and Molecular Function of Cardiovascular Diseases, The Second Hospital of Tianjin Medical University, Tianjin Institute of Cardiology, Tianjin, China.

Medicine
|May 10, 2024
PubMed
概括

炎症标志物,包括中性粒细胞与淋巴细胞比率 (NLR) 和红细胞分布宽度 (RDW),预测皮肤冠状动脉干预 (PCI) 后的一年死亡率. 较高的NLR和RDW水平与风险增加有关,改善了患者风险分层.